|
|
|
Stem Cell Related Patent Number US6022534
| Title: | Lymphotactin uses | | Inventors: | Hedrick, Joseph A.; Plainsboro, NJ, USA
Hudak, SUSA
n A.; Redwood City, CA, USA
Zlotnik, Albert; Palo Alto, CA, USA | | Summary: | Described herein are methods of lymphotactin use in increasing local populations of natural killer cells and cytotoxic T lymphocyte cells in mammals. The invention relates to the use of lymphotactin or lymphotactin antagonists for therapeutic administration to a mammal for the purpose either of attracting certain cell types or of blocking and preventing such an attraction. Methods of protecting stem cells with lymphotactin and its antagonists are further disclosed. Also included are therapeutic and experimental applications. | | Abstract: | This invention relates to the use of lymphotactin or lymphotactin antagonists for administration to an animal. The administration of these therapeutic entities will attract certain cell types, or can be blocked to prevent such attraction. It also provides means to protect stem cells. | | US Patent Website: | Click Here for Full Text of Patent | | Title Number: | US6022534 | | Application Number: | US1997000956250 | | Date Filed: | 22/10/1997 | | Date Published: | 08/02/2000 | | Assignee: | Schering Corporation, Kenilworth, NJ, USA |
|
|
